Taysha Gene Therapies, Inc. TSHA Other, net
Other, net at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s other, net?
- Taysha Gene Therapies, Inc. (TSHA) reported other, net of $19K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s other, net changed year-over-year?
- Taysha Gene Therapies, Inc.'s other, net increased by 123.8% year-over-year, from -$80K to $19K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other, net?
- Over 2 years (2021 to 2025), Taysha Gene Therapies, Inc.'s other, net has grown at a -19.0% compound annual growth rate (CAGR), from -$514K to -$337K.
- What does other, net mean?
- Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.